Showing 1 - 16 results of 16 for search 'David G. Strauss', query time: 0.08s Refine Results
  1. 1
    Quantitative Systems Pharmacology Models for a New International Cardiac Safety Regulatory Paradigm: An Overview of the Comprehensive In Vitro Proarrhythmia Assay In Silico Modeling Approach

    Quantitative Systems Pharmacology Models for a New International Cardiac Safety Regulatory Paradigm: An Overview of the Comprehensive In Vitro Proarrhythmia Assay In Silico Modelin... by Zhihua Li, Christine Garnett, David G. Strauss

    Published 2019-06-01
    Get full text
    Article
  2. 2
    Reproducibility of drug-induced effects on the contractility of an engineered heart tissue derived from human pluripotent stem cells

    Reproducibility of drug-induced effects on the contractility of an engineered heart tissue derived from human pluripotent stem cells by Ayesha Arefin, Ayesha Arefin, Melissa Mendoza, Keri Dame, M. Iveth Garcia, David G. Strauss, David G. Strauss, Alexandre J. S. Ribeiro

    Published 2023-07-01
    Get full text
    Article
  3. 3
    Predicting potential adverse events using safety data from marketed drugs

    Predicting potential adverse events using safety data from marketed drugs by Chathuri Daluwatte, Peter Schotland, David G. Strauss, Keith K. Burkhart, Rebecca Racz

    Published 2020-04-01
    Get full text
    Article
  4. 4
    Clinical Trial in a Dish: Personalized Stem Cell–Derived Cardiomyocyte Assay Compared With Clinical Trial Results for Two QT‐Prolonging Drugs

    Clinical Trial in a Dish: Personalized Stem Cell–Derived Cardiomyocyte Assay Compared With Clinical Trial Results for Two QT‐Prolonging Drugs by Ksenia Blinova, Derek Schocken, Dakshesh Patel, Chathuri Daluwatte, Jose Vicente, Joseph C. Wu, David G. Strauss

    Published 2019-11-01
    Get full text
    Article
  5. 5
    Correction: Electrocardiographic Biomarkers for Detection of Drug-Induced Late Sodium Current Block.

    Correction: Electrocardiographic Biomarkers for Detection of Drug-Induced Late Sodium Current Block. by Jose Vicente, Lars Johannesen, Meisam Hosseini, Jay W Mason, Philip T Sager, Esther Pueyo, David G Strauss

    Published 2018-01-01
    Get full text
    Article
  6. 6
    Electrocardiographic Biomarkers for Detection of Drug-Induced Late Sodium Current Block.

    Electrocardiographic Biomarkers for Detection of Drug-Induced Late Sodium Current Block. by Jose Vicente, Lars Johannesen, Meisam Hosseini, Jay W Mason, Philip T Sager, Esther Pueyo, David G Strauss

    Published 2016-01-01
    Get full text
    Article
  7. 7
    Optimization of an In silico Cardiac Cell Model for Proarrhythmia Risk Assessment

    Optimization of an In silico Cardiac Cell Model for Proarrhythmia Risk Assessment by Sara Dutta, Kelly C. Chang, Kylie A. Beattie, Jiansong Sheng, Phu N. Tran, Wendy W. Wu, Min Wu, David G. Strauss, Thomas Colatsky, Zhihua Li

    Published 2017-08-01
    Get full text
    Article
  8. 8
    Corrigendum: Optimization of an In silico Cardiac Cell Model for Proarrhythmia Risk Assessment

    Corrigendum: Optimization of an In silico Cardiac Cell Model for Proarrhythmia Risk Assessment by Sara Dutta, Kelly C. Chang, Kylie A. Beattie, Jiansong Sheng, Phu N. Tran, Wendy W. Wu, Min Wu, David G. Strauss, Thomas Colatsky, Zhihua Li

    Published 2017-12-01
    Get full text
    Article
  9. 9
    Evaluating kratom alkaloids using PHASE.

    Evaluating kratom alkaloids using PHASE. by Christopher R Ellis, Rebecca Racz, Naomi L Kruhlak, Marlene T Kim, Alexey V Zakharov, Noel Southall, Edward G Hawkins, Keith Burkhart, David G Strauss, Lidiya Stavitskaya

    Published 2020-01-01
    Get full text
    Article
  10. 10
    Uncertainty Quantification Reveals the Importance of Data Variability and Experimental Design Considerations for in Silico Proarrhythmia Risk Assessment

    Uncertainty Quantification Reveals the Importance of Data Variability and Experimental Design Considerations for in Silico Proarrhythmia Risk Assessment by Kelly C. Chang, Sara Dutta, Gary R. Mirams, Kylie A. Beattie, Jiansong Sheng, Phu N. Tran, Min Wu, Wendy W. Wu, Thomas Colatsky, David G. Strauss, Zhihua Li

    Published 2017-11-01
    Get full text
    Article
  11. 11
    Developing an animal model to detect drug–drug interactions impacting drug-induced respiratory depression

    Developing an animal model to detect drug–drug interactions impacting drug-induced respiratory depression by Lin Xu, Ashok Chockalingam, Sharron Stewart, Katherine Shea, Murali K. Matta, Suresh Narayanasamy, Nageswara R. Pilli, Donna A. Volpe, James Weaver, Hao Zhu, Michael C. Davis, David G. Strauss, Rodney Rouse

    Published 2020-01-01
    Get full text
    Article
  12. 12
    Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block.

    Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block. by Phu N Tran, Jiansong Sheng, Aaron L Randolph, Claudia Alvarez Baron, Nicolas Thiebaud, Ming Ren, Min Wu, Lars Johannesen, Donna A Volpe, Dakshesh Patel, Ksenia Blinova, David G Strauss, Wendy W Wu

    Published 2020-01-01
    Get full text
    Article
  13. 13
    Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation

    Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation by Andrés Rubiano, Amruta Indapurkar, Ryosuke Yokosawa, Alina Miedzik, Barry Rosenzweig, Ayesha Arefin, Chloe M. Moulin, Keri Dame, Neil Hartman, Donna A. Volpe, Murali K. Matta, David J. Hughes, David G. Strauss, Tomasz Kostrzewski, Alexandre J. S. Ribeiro

    Published 2021-05-01
    Get full text
    Article
  14. 14
    In Memory of Professor Galen S. Wagner M.D., Ph.D. (1939 - 2016) – our mentor, colleague and friend

    In Memory of Professor Galen S. Wagner M.D., Ph.D. (1939 - 2016) – our mentor, colleague and friend by Marylin Wagner, Laura Wagner, Chris Wagner, Samuel J. Bell, Brit W. Nicholson, David G. Strauss, Stafford Warren, Ole Pahlm, Ljuba Bacharova, Eric Eisenstein, Jonathan Lipton, Maria Sejersten Ripa, Rasmus Sejersten Ripa, Stefan Nelwan, Ioana Mozos, Michael Ringborn, Gulmira Kudaiberdieva

    Published 2017-06-01
    Get full text
    Article
  15. 15
    International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment

    International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment by Ksenia Blinova, Qianyu Dang, Daniel Millard, Godfrey Smith, Jennifer Pierson, Liang Guo, Mathew Brock, Hua Rong Lu, Udo Kraushaar, Haoyu Zeng, Hong Shi, Xiaoyu Zhang, Kohei Sawada, Tomoharu Osada, Yasunari Kanda, Yuko Sekino, Li Pang, Tromondae K. Feaster, Ralf Kettenhofen, Norman Stockbridge, David G. Strauss, Gary Gintant

    Published 2018-09-01
    Get full text
    Article
  16. 16
    New science, drug regulation, and emergent public health issues: The work of FDA’s division of applied regulatory science

    New science, drug regulation, and emergent public health issues: The work of FDA’s division of applied regulatory science by Kimberly Chiu, Rebecca Racz, Keith Burkhart, Jeffry Florian, Kevin Ford, M. Iveth Garcia, Robert M. Geiger, Kristina E. Howard, Paula L. Hyland, Omnia A. Ismaiel, Naomi L. Kruhlak, Zhihua Li, Murali K. Matta, Kristin W. Prentice, Kristin W. Prentice, Aanchal Shah, Aanchal Shah, Lidiya Stavitskaya, Donna A. Volpe, James L. Weaver, Wendy W. Wu, Rodney Rouse, David G. Strauss

    Published 2023-01-01
    Get full text
    Article

Search Tools: